ICCM IceCure Medical Ltd. - Ordinary Shares
1.570USD-7.10%Mkt Cap: 7.28M $P/E: —3d ago
IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, …
Industry Peers
Medical Devices$169.83BUSDP/E 31.6
$110.49BUSDP/E 21.2
$105.65BUSDP/E 28.5
$61.74BUSDP/E 17.2
$49.03BUSDP/E 50.7
$46.06BUSDP/E 19.2
$32.21BUSDP/E 33.7
$29.24BUSDP/E 14.8
$23.38BUSDP/E 18.5
$22.58BUSDP/E 18.5
$20.33BUSDP/E 25.5
$17.06BUSDP/E 27.9
$16.84BUSDP/E 21.4
$12.51BUSDP/E 77.8
$12.18BUSD
$11.06BUSDP/E 18.0
$10.15BUSDP/E 19.3
$9.65BUSDP/E 27.4
$9.88BUSDP/E 45.0
$9.66BUSD
| Headline | Source | Time |
|---|---|---|
Older | ||
Icecure Medical Ltd (ICCM) (Q2 2026) Earnings Call Highlights: Revenue Surges 45% as US ... Company reports strong commercial momentum with expanding gross margins and advancing CHoICE study, despite widening net loss. | ||
 IceCure Medical (ICCM) Q2 2026 Earnings Call Transcript Revenue surged 45% as U.S. breast cancer clearance drives commercial expansion. | ||
 IceCure Medical Ltd Q2 2026 Earnings Call Summary Moby summary of IceCure Medical Ltd's Q2 2026 earnings call | ||
 Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates Establishment Labs (ESTA) delivered earnings and revenue surprises of -14.71% and +3.53%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||